Prevention of Vision Loss From Diabetes Counseling, persistence, and multiple telephone calls along with low-literacy level educational material impact.

Slides:



Advertisements
Similar presentations
OUT OF SIGHT The Rise and Rise of Diabetes and the Need for a Nationwide Retinopathy Screening Program Dr Mohamed Dirani Health Services and Evaluative.
Advertisements

1 ICD-9-CM Coordination and Maintenance Committee Meeting October 8 th, 2004 Matthew J. Sheetz, MD, PhD Promoting Clear Identification of Diabetic Retinopathy.
The Diabetic Retinopathy Clinical Research Network
Evan (Jake) Waxman MD PhD
Welcome to CNIB’s InFocus Webinar Series
Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012
“Prevention of Blindness” Is diabetic retinopathy a preventable disease? By Amr ElKamshoushy, MD.
Prevalence of Diabetic Retinopathy In Diabetic patients cared for at the Family Care Center at RCRMC Kam Chan, DO [ role of BP & glycemic control ]
DIABETIC RETINOPATHY.
Rites of Sight Your Second 50 years A Presentation of the American Optometric Association.
By: Marc Wentz, Regina Carson, Jonathan Nissen, Cydney Williams
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Serum Lipids and Proliferative Diabetic Retinopathy Klein BEK, Myers CE, Howard.
Child Health Disparities Denice Cora-Bramble, MD, MBA Professor of Pediatrics, George Washington University Executive Director Goldberg Center for Community.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
PREDICTORS OF DIABETIC WOUND HEALING BY RACIAL/ETHNIC CATEGORIES Ranjita Misra 1, Lynn Lambert 2, David Vera 3, Ashley Mangaraj 3, Suchin R Khanna 3, Chandan.
Diabetes: The Numbers Michigan Diabetes Partners in Action and Michigan Department of Community Health Diabetes: The Numbers Adapted from the National.
CNIB: SEEING BEYOND VISION LOSS
Diabetes Disparities & Its Effects on Minority Populations Appathurai Balamurugan, MD, MPH Section Chief, Chronic Disease Epidemiology, ADHHS Assistant.
DIABETES AND EYE DISEASE: LEARNING OBJECTIVES
The findings and conclusions in this presentation are those of the author and do not necessarily represent the views of the CDC. CDC ‘s Role in Vision.
Diabetic Retinopathy. Diabetic retinopathy is the most common cause of new cases of blindness among adults years of age. Each year, between 12,000.
These are our patients… …old and young alike …men, women and children.
The Goal is in Sight: Eye Care Concerns for Patients with Diabetes
Tracking Healthy People 2010 Vision Objectives Kathleen M. Turczyn, MPH National Center for Health Statistics.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Knowledge, Cancer Fatalism and Spirituality as Predictors of Breast Cancer Screening Practices for African American and Caucasian Women Staci T. Anderson,
BSI and Federal Health Care Reform Patient Protection and Affordable Care Act, as amended by Reconciliation Behavioral Screening and Intervention (BSI)
The Diabetic Retinopathy Clinical Research Network
Everyone’s Vision Can Change With Age  Some vision changes make it difficult to perform everyday activities.  These changes can also impact one’s feeling.
Diabetes and the Eyes Kenyon Anderson, O.D.. Blindness Risk Diabetic eye disease, caused by diabetes, is a leading cause of blindness and vision loss.
Prospective Telemedicine Screening for Diabetics at High Risk for Retinopathy. PI- Jayne S Weiss, MD LSUHSC-NO.
F ocus Area 28 Vision and Hearing Progress Review October 20, 2004.
1 NHLBI/NEI National Institutes of Health NHLBI/NEI National Institutes of Health.
The State of Arthritis in Michigan 2005 Michigan Department of Community Health Chronic Disease Epidemiology Section, Division of Genomics, Perinatal.
Diabetic Retinopathy.
An Innovative Approach to Managing Diabetes in a Large Public Health System Donna J. Calvin, PhD, FNP-BC, CNN Post Doctoral Research Associate University.
Factors Associated with Changes in Visual Acuity and OCT Thickness at 1 Year after Treatment for Diabetic Macular Edema Sponsored by the National Eye Institute,
Inci Irak-Dersu MD 1, Appathurai Balamurugan, MD MPH 2 1 College of Medicine, University of Arkansas Medical Sciences 2 Fay W. Boozman College of Public.
Name Institution Date. Description of the Target Population The target population for this study are the African- American population aged between
The findings and conclusions in this presentation are those of the author and do not necessarily represent the views of the CDC. Diabetes Prevention Ann.
ABSTRACT Diabetes is a public health issue of growing magnitude. It currently ranks among the top ten leading causes of death in the United States. To.
Diabetic Retinopathy. Early detection, education, and research are the keys to preventing diabetic retinopathy. Skilled professionals, such as TVI, are.
Diabetes and the Eye Karen B. Saland, M.D. August 18, 2008.
Diabetic Retinopathy: A technological and innovative intervention to improve detection of target organ damage S. Naidu, MD, MPH, FAAFP Medical Director.
The Diabetic Retinopathy Clinical Research Network
Josephine Carlos-Raboca, M.D. Makati Medical Center
© 2010 Jones and Bartlett Publishers, LLC1 Addressing Health Disparities in the 21st Century Chapter 1.
RETINOPATHY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Philip Anderton BOptom PhD Visiting Optometrist Manilla Health Service HNEAHS.
A. B Founded in 1908, Prevent Blindness America is the nation’s leading volunteer eye health and safety organization dedicated to fighting blindness.
Blindness or low vision effects more than 3 million Americans 40 years and older, and this number is projected to reach 5.5 million by In addition.
TM Making the Case to Insurance Purchasers for Tobacco Use Treatment Coverage Maya Vijayaraghavan, Ph.D. Office on Smoking and Health National Conference.
Glaucoma Care Project Team Members: Geoffrey T. Emerick, M.D. Erin Herlihy, B.S. Marilyn Hauser, M.B.A. Dianna Greening, R.N. Walter M. Jay, M.D Opportunity.
Factors Predicting Stage of Adoption for Fecal Occult Blood Testing and Colonoscopy among Non-Adherent African Americans Hsiao-Lan Wang, PhD, RN, CMSRN,
Efficacy of a “One-Shot” Computerized, Individualized Intervention to Increase Condom Use and Decrease STDs among Clinic Patients with Main Partners Diane.
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Awareness and Knowledge of Emergent Ophthalmic Disease Uhr JH, Mishra K, Wei C,
The Diabetic Retinopathy Clinical Research Network DRCR.net Prompt PRP vs Ranibizumab+Deferred PRP for PDR Study Jeffrey G. Gross, M.D. – Protocol Chair.
CHRISTINA SHEPPLER, PHD Devers Eye Institute Telehealth Alliance of Oregon 2013 Implementing a Telemedicine Program for Diabetic Retinopathy Screening.
Healthy People 2010 Focus Area 5: Diabetes Progress Review October 20, 2006.
Printed by Natural History of Sun Protection Behaviors in a Cohort of Children in Colorado Nancy L. Asdigian PhD,* Lori A. Crane.
Glaucoma Lily T. Im, MD. What is glaucoma?   Glaucoma is a group of diseases that damage the eye’s optic nerve and can result in vision loss and blindness.
How Diabetes Steals Vision from Your Patients
Copyright © 2008 Delmar. All rights reserved. Chapter 4 Epidemiology and Public Health Nursing.
Arnold School of Public Health Health Services Policy and Management 1 Women’s Cancer Screening Services Utilization Versus Their Insurance Source Presenter:
The Diabetic Retinopathy Clinical Research Network
Age-Related Eye Diseases You Should Be Tested For.
Prevalence of Diabetic Retinopathy
The Diabetic Retinopathy Clinical Research Network
Medicare Diabetes Prevention Program
Presentation transcript:

Prevention of Vision Loss From Diabetes Counseling, persistence, and multiple telephone calls along with low-literacy level educational material impact screening for diabetic retinopathy in inner-city African American communities Crystal J. Howard-Century, MA, MS, CHES, CCRA Department of Health and Behavior Studies Center for Health Promotion Columbia University Teachers College

OVERVIEW “Purpose of Presentation”  Qualitative doctoral research based on * NEI-supported randomized controlled trial (N=280)  Health education intervention impacts screening and vision loss from diabetic retinopathy  Health disparities: target African Americans  Intervention success: one-on-one culturally sensitive telephone counseling with diabetes education (N=130)  Sample intervention (N=20) motivation and barriers to ophthalmic screening, persistence, behavioral strategies * Results: Am J Public Health. 1999;89:

DISABILITY IN THE U.S.   Report of disabling conditions, 49 million  Report of disabling conditions, 54 million   Cost of visual disorders and disabilities $14.1 billion in 1981 to $38.4 billion ($22.3 billion direct, $16.1 billion indirect)

PREVALENCE OF DISABILITIES U.S. BUREAU OF CENSUS, CDC (SIPP DATA) MMWR Morb Mortal Wkly Rep. 2001;50: , 44 million reported a disability; 41.2 million reported main cause. Total 30 conditions

STATISTICS: VISION   Current estimates: Restrictive Definition - Approximately 3 million Americans have some visual disorder - More than 900,000 classified as legally blind visual acuity of 20/200 or worse in the better eye with corrective lenses or visual field restricted to 20 degrees diameter or less (tunnel vision) in the better eye - Almost 200,000 Americans are totally blind

STATISTICS: VISION (continued)   Current estimates: Broader Definition - Includes vision problems impacting ADL, activities of daily living - Up to 14 million Americans experience impairment of their vision Normal Fundus Photo: National Eye Institute, National Institutes of Health

CAUSES OF VISUAL IMPAIRMENT “Diabetes”   Approximately 12,000 to 24,000 people become blind each year   Accounts for greater than 12% of new blindness   Disparity: African Americans 40% higher frequency of severe visual impairment than Whites  Diabetic Retinopathy: leading cause of new cases of blindness, adults between ages 20 to 74

DIABETIC RETINOPATHY “Significant Threat to Vision”   Microvascular complication of type 1 and type 2; microaneurysms, hemorrhages, cotton-wool spots, thickening, hard exudates, retinal detachment Proliferative Diabetic Retinopathy (PDR) abnormal new blood vessels, scar tissue Photos: National Eye Institute, National Institutes of Health Background Diabetic Retinopathy (BDR) deterioration in small blood vessels, swell, leak fluid

DIABETIC RETINOPATHY “Significant Threat to Vision” (cont)   After 20 years, nearly all type 1 and > 60% type 2 have some degree of retinopathy   Incidence Data * WESDR (Wisconsin Epidemiologic Study of Diabetic Retinopathy): Diagnosed ~7.8 million people with diabetes in ,000 will develop PDR each year - 40,000 will develop PDR + risk severe vision loss - 95,000 develop macular edema * Source: Diabetes in America. 1995;

BENEFITS OF SCREENING   Landmark trials, therapeutic benefit - Intensive diabetes management: DCCT and UKPDS - Efficacy of timely treatment: DRS and ETDRS   50% reduction in risk of severe visual loss and vitrectomy   Asymptomatic   Saves vision, low cost less than disability payments   Treatment modalities: prevent loss or delay onset

DIABETES STANDARD OF CARE   Annual retinal examination - dilated eye examination   Ophthalmologist or Optometrist, knowledgeable and experienced in diabetic retinopathy   Dilated ETDRS seven-standard field stereoscopic 30° fundus photographs more sensitive   Severe NPDR, macular edema, PDR - prompt referral to trained eye care specialist

ROAD MAP TO BETTER HEALTH “21 ST Century Objectives”   Healthy People 2010, plans to improve health - Goals: increase quality and years of healthy life; eliminate health disparities objectives organized into 28 focus areas : Increase the proportion of adults with diabetes who have an annual dilated eye exam : Increase the proportion of persons who have a dilated eye examination at appropriate intervals : Reduce visual impairment due to diabetic retinopathy

TELEPHONE COUNSELING INCREASES SCREENING   Results of this intervention - Screening: intervention group, 54.7% versus 27.3% control group   Preliminary chart audit, African Americans 47% screening rate   6-month intervention time-frame; weekly calls, end with self-report (some cases beyond 6 months)   Verify dilated eye exam documentation (chart audit)

THE INTERVENTION: DEMOGRAPHICS (expressed in percentage) Intervention Subjects (N = 137) Male34.3 Married33.6 Unemployed73.0 Completed HS43.8 Receives Medicaid43.0 Receives Medicare22.4 Insured70.1 Family Income69.1 (< 10,000) Mean Age (SD)55.6 (12.9) Mean Duration of Disease (SD)8.1 (7.4)

METHOD  Select sample, 20 Intervention cases - Aliases assigned to protect identities - Include those who did and did not have the dilated eye exam - Based on degrees of difficulty and barriers encountered - Include subjects from each recruitment center  Case Study Method - Multiple case design, exploratory and descriptive - Case histories or portraits from multiple sources

NUMBER OF TELEPHONE CALLS (N=20) Mean (SD) = 33.9 ( 30.9) Max # calls = 130 [Lenny] Min # calls = 8 [Sereena]

NUMBER OF MINUTES WITH EACH SUBJECT (N=20) Mean (SD) = (85.1) Max # minutes = 383 [Carla] Min # minutes = 27 [Marie]

NUMBER OF MONTHS (N=20) Mean (SD) = 5.2 ( 2.3) Max # months = 10 [Princess] Min # months = 1.5 [Bertha]

NUMBER OF BARRIERS IDENTIFIED (N=20) Mean (SD) = 5.5 (3.3) Max # barriers = 11 [Lonetta] Min # barriers = 0 [Bertha; Calvin]

OBSTACLES TO SCREENING Yes Dilated Eye Exam  Bertha  none  Heather  health  Gayle  health  Junior  health  Ethel  life events  Sereena  family  Vaughn  family  Calvin  none  Marie  health  Vanessa  medical syst No Dilated Eye Exam No Dilated Eye Exam  Julio  money  Lonetta  health  Ella  health  Tony  life events  Al  medical system  Carla  medical system  Lenny  family situation  Princess  external force  Wally  medical system  Jackson  external force

MOTIVATION FOR SCREENING Yes Dilated Eye Exam  Bertha  social network  Heather  health  Gayle  health  Junior  social network  Ethel  social network  Sereena  social network  Vaughn  social network  Calvin  MD  Marie  health  Vanessa  health No Dilated Eye Exam No Dilated Eye Exam  Julio  social network  Lonetta  health  Ella  not ready  Tony  not ready  Al  health  Carla  health  Lenny  social network  Princess  social network  Wally  social network  Jackson  social network

TRANSLATE OBJECTIVES INTO ACTION   Understand obstacles to compliance and motivation   Tailor intervention based on subject’s experiences   Be persistent Photo: National Eye Institute, National Institutes of Health

CONCLUSION  Assess Stages of Change  Utilize behavioral strategies to overcome challenges, transition through Stages - Motivational Interviewing (i.e., empathic listening, cognitive dissonance, decisional balance) - Relapse Prevention (i.e., identify high-risk situations, effective cognitive behavioral response, increase self-efficacy)  Health Educator needs cultural sensitivity  Design culturally appropriate material  Establish and maintain rapport  Include social networks